1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Electrocompetent Cells Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cloned Competent Cells
  • 1.2.3 Agrobacterium tumefaciens Competent Cells
  • 1.2.4 Expression Competent Cells
• 1.3 Market by Application
  • 1.3.1 Global Electrocompetent Cells Market Share by Application: 2020 VS 2026
  • 1.3.2 Subcloning & Routine Cloning
  • 1.3.3 Phage Display Library Construction
  • 1.3.4 Toxic/Unstable Dna Cloning
  • 1.3.5 High-Throughput Cloning
  • 1.3.6 Protein Expression
  • 1.3.7 Mutagenesis
  • 1.3.8 Single-Stranded Dna Production
  • 1.3.9 Bacmid creation
  • 1.3.10 Cre-lox recombination (PIR1/PIR2)
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Electrocompetent Cells Market Perspective (2015-2026)
• 2.2 Global Electrocompetent Cells Growth Trends by Regions
  • 2.2.1 Electrocompetent Cells Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Electrocompetent Cells Historic Market Share by Regions (2015-2020)
  • 2.2.3 Electrocompetent Cells Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Electrocompetent Cells Players by Market Size
  • 3.1.1 Global Top Electrocompetent Cells Players by Revenue (2015-2020)
  • 3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2015-2020)
• 3.2 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Electrocompetent Cells Revenue
• 3.4 Global Electrocompetent Cells Market Concentration Ratio
  • 3.4.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2019
• 3.5 Key Players Electrocompetent Cells Area Served
• 3.6 Key Players Electrocompetent Cells Product Solution and Service
• 3.7 Date of Enter into Electrocompetent Cells Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Electrocompetent Cells Breakdown Data by Type (2015-2026)

• 4.1 Global Electrocompetent Cells Historic Market Size by Type (2015-2020)
• 4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2021-2026)

5 Electrocompetent Cells Breakdown Data by Application (2015-2026)

• 5.1 Global Electrocompetent Cells Historic Market Size by Application (2015-2020)
• 5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Electrocompetent Cells Market Size (2015-2026)
• 6.2 North America Electrocompetent Cells Market Size by Type (2015-2020)
• 6.3 North America Electrocompetent Cells Market Size by Application (2015-2020)
• 6.4 North America Electrocompetent Cells Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Electrocompetent Cells Market Size (2015-2026)
• 7.2 Europe Electrocompetent Cells Market Size by Type (2015-2020)
• 7.3 Europe Electrocompetent Cells Market Size by Application (2015-2020)
• 7.4 Europe Electrocompetent Cells Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Electrocompetent Cells Market Size (2015-2026)
• 8.2 China Electrocompetent Cells Market Size by Type (2015-2020)
• 8.3 China Electrocompetent Cells Market Size by Application (2015-2020)
• 8.4 China Electrocompetent Cells Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Electrocompetent Cells Market Size (2015-2026)
• 9.2 Japan Electrocompetent Cells Market Size by Type (2015-2020)
• 9.3 Japan Electrocompetent Cells Market Size by Application (2015-2020)
• 9.4 Japan Electrocompetent Cells Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Electrocompetent Cells Market Size (2015-2026)
• 10.2 Southeast Asia Electrocompetent Cells Market Size by Type (2015-2020)
• 10.3 Southeast Asia Electrocompetent Cells Market Size by Application (2015-2020)
• 10.4 Southeast Asia Electrocompetent Cells Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Merck KGaA
  • 11.1.1 Merck KGaA Company Details
  • 11.1.2 Merck KGaA Business Overview
  • 11.1.3 Merck KGaA Electrocompetent Cells Introduction
  • 11.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2015-2020))
  • 11.1.5 Merck KGaA Recent Development
• 11.2 Thermo Fisher Scientific
  • 11.2.1 Thermo Fisher Scientific Company Details
  • 11.2.2 Thermo Fisher Scientific Business Overview
  • 11.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction
  • 11.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.2.5 Thermo Fisher Scientific Recent Development
• 11.3 Agilent Technologies
  • 11.3.1 Agilent Technologies Company Details
  • 11.3.2 Agilent Technologies Business Overview
  • 11.3.3 Agilent Technologies Electrocompetent Cells Introduction
  • 11.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.3.5 Agilent Technologies Recent Development
• 11.4 Takara Bio
  • 11.4.1 Takara Bio Company Details
  • 11.4.2 Takara Bio Business Overview
  • 11.4.3 Takara Bio Electrocompetent Cells Introduction
  • 11.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.4.5 Takara Bio Recent Development
• 11.5 Promega Corporation
  • 11.5.1 Promega Corporation Company Details
  • 11.5.2 Promega Corporation Business Overview
  • 11.5.3 Promega Corporation Electrocompetent Cells Introduction
  • 11.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.5.5 Promega Corporation Recent Development
• 11.6 Beijing TransGen Biotech
  • 11.6.1 Beijing TransGen Biotech Company Details
  • 11.6.2 Beijing TransGen Biotech Business Overview
  • 11.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction
  • 11.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.6.5 Beijing TransGen Biotech Recent Development
• 11.7 GeneScript Corporation
  • 11.7.1 GeneScript Corporation Company Details
  • 11.7.2 GeneScript Corporation Business Overview
  • 11.7.3 GeneScript Corporation Electrocompetent Cells Introduction
  • 11.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.7.5 GeneScript Corporation Recent Development
• 11.8 Yeastern Biotech
  • 11.8.1 Yeastern Biotech Company Details
  • 11.8.2 Yeastern Biotech Business Overview
  • 11.8.3 Yeastern Biotech Electrocompetent Cells Introduction
  • 11.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.8.5 Yeastern Biotech Recent Development
• 11.9 New England Biolabs
  • 11.9.1 New England Biolabs Company Details
  • 11.9.2 New England Biolabs Business Overview
  • 11.9.3 New England Biolabs Electrocompetent Cells Introduction
  • 11.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.9.5 New England Biolabs Recent Development
• 11.10 QIAGEN N.V.
  • 11.10.1 QIAGEN N.V. Company Details
  • 11.10.2 QIAGEN N.V. Business Overview
  • 11.10.3 QIAGEN N.V. Electrocompetent Cells Introduction
  • 11.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2015-2020)
  • 11.10.5 QIAGEN N.V. Recent Development
• 11.11 OriGene Technologies
  • 10.11.1 OriGene Technologies Company Details
  • 10.11.2 OriGene Technologies Business Overview
  • 10.11.3 OriGene Technologies Electrocompetent Cells Introduction
  • 10.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.11.5 OriGene Technologies Recent Development
• 11.12 Lucigen
  • 10.12.1 Lucigen Company Details
  • 10.12.2 Lucigen Business Overview
  • 10.12.3 Lucigen Electrocompetent Cells Introduction
  • 10.12.4 Lucigen Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.12.5 Lucigen Recent Development
• 11.13 Zymo Research
  • 10.13.1 Zymo Research Company Details
  • 10.13.2 Zymo Research Business Overview
  • 10.13.3 Zymo Research Electrocompetent Cells Introduction
  • 10.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.13.5 Zymo Research Recent Development
• 11.14 Bio-Rad Laboratories
  • 10.14.1 Bio-Rad Laboratories Company Details
  • 10.14.2 Bio-Rad Laboratories Business Overview
  • 10.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction
  • 10.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.14.5 Bio-Rad Laboratories Recent Development
• 11.15 Bioline
  • 10.15.1 Bioline Company Details
  • 10.15.2 Bioline Business Overview
  • 10.15.3 Bioline Electrocompetent Cells Introduction
  • 10.15.4 Bioline Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.15.5 Bioline Recent Development
• 11.16 Delphi Genetics
  • 10.16.1 Delphi Genetics Company Details
  • 10.16.2 Delphi Genetics Business Overview
  • 10.16.3 Delphi Genetics Electrocompetent Cells Introduction
  • 10.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.16.5 Delphi Genetics Recent Development
• 11.17 IBA GmBH
  • 10.17.1 IBA GmBH Company Details
  • 10.17.2 IBA GmBH Business Overview
  • 10.17.3 IBA GmBH Electrocompetent Cells Introduction
  • 10.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.17.5 IBA GmBH Recent Development
• 11.18 Cell Applications
  • 10.18.1 Cell Applications Company Details
  • 10.18.2 Cell Applications Business Overview
  • 10.18.3 Cell Applications Electrocompetent Cells Introduction
  • 10.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.18.5 Cell Applications Recent Development
• 11.19 BioDynamics Laboratory
  • 10.19.1 BioDynamics Laboratory Company Details
  • 10.19.2 BioDynamics Laboratory Business Overview
  • 10.19.3 BioDynamics Laboratory Electrocompetent Cells Introduction
  • 10.19.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.19.5 BioDynamics Laboratory Recent Development
• 11.20 Scarab Genomics
  • 10.20.1 Scarab Genomics Company Details
  • 10.20.2 Scarab Genomics Business Overview
  • 10.20.3 Scarab Genomics Electrocompetent Cells Introduction
  • 10.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2015-2020)
  • 10.20.5 Scarab Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Electrocompetent Cells Scope and Market Size
Electrocompetent Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Electrocompetent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells

Market segment by Application, split into
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)

Based on regional and country-level analysis, the Electrocompetent Cells market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Electrocompetent Cells market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics